mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.14 |
0.006 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.007 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.008 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |